Skip to main content

Table 4 Multivariate Cox regression models for major adverse cardiac events and target lesion failure

From: Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

  Hazard ratio Lower 95% CI Higher 95% CI p-value
A. Variable for outcome MACE
 Gender—female vs. male 1.78 0.58 5.45 0.31
 Age at device implantation 1.02 0.98 1.07 0.39
 PCI-indication—ACS vs. non-ACS 0.67 0.27 1.62 0.37
 Insulin-treated DM—no vs. yes 2.01 0.80 5.04 0.14
B1. Variable for outcome TLF
 Gender—female vs. male 3.44 0.76 15.47 0.11
 Age at device implantation 1.03 0.98 1.09 0.27
 PCI-indication—ACS vs. non-ACS 0.61 0.22 1.65 0.33
 Insulin-treated DM—no vs. yes 2.54 0.93 6.97 0.07
B2. Variable for outcome TLF
 Gender—female vs. male 2.87 0.65 12.69 0.17
 Age at device implantation 1.03 0.97 1.09 0.32
 PCI-indication—ACS vs. non-ACS 0.64 0.24 1.74 0.39
 Postdilatation performed—no vs. yes 0.40 0.15 1.07 0.07
  1. Section A. Multivariate Cox regression model for major adverse cardiac events adjusted with age, gender, PCI-indication and diabetes mellitus treated with insulin at hospital admission. Section B. The same model calculated for target lesion failure (B1) and a model with incorporation of postdilatation (B2). Risk factors are given in hazard ratio’s with 95% confidence intervals with corresponding p-values. A p-value < 0.05 was uphold as formally statistical significant. Insulin-treated diabetes mellitus was identified as variable that showed a trend towards a predictor for major adverse cardiac events. Insulin-treated diabetes mellitus and absence of postdilatation were identified as variables that showed a trend towards a predictor for target lesion failure
  2. MACE major adverse cardiac events, CI confidence interval, PCI percutaneous coronary intervention, ACS acute coronary syndrome, DM diabetes mellitus, TLF target lesion failure